Health Care & Life Sciences » Pharmaceuticals | China Medical System Holdings Ltd.

China Medical System Holdings Ltd.

China Medical System Holdings Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.88
Market Cap
HKD18.63 B
Shares Outstanding
2.48 B
Public Float
1.32 B

Profile

Address
6/F-8/F, Block B
Shenzhen Guangdong 518052
China
Employees -
Website http://www.cms.net.cn
Updated 07/08/2019
China Medical System Holdings Ltd. engages in the provision of pharmaceutical products and services. The company focuses on the manufacture, marketing, promotion, and sale of drugs. Its products include Plendi, XinHuoSu, Stulln, XiDaKang, YiNuoShu, DanShenTong, Hirudoid, NuoDiKang, Combizym, GanFuLe, Imdur, Parlodel, Lamisil, YinLianQingGan, and MOVICOL.

Financials

View All

Kong Lam
Chairman, President & Chief Executive Officer
Hong Bing Chen
Chief Operating Officer, Executive Director & VP